Johannes Hampl, Yueh-hsiu Chien, Mark M Davis  Immunity 

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Volume 37, Issue 3, Pages (September 2012)
by Jacob Rachmilewitz, Gregory J
Volume 124, Issue 5, Pages (May 2003)
Volume 15, Issue 1, Pages (July 2001)
Specific Lysis of Melanoma Cells by Receptor Grafted T Cells is Enhanced by Anti- Idiotypic Monoclonal Antibodies Directed to the scFv Domain of the Receptor 
Volume 16, Issue 2, Pages (February 2002)
Volume 29, Issue 6, Pages (December 2008)
Marc Hertz, David Nemazee  Immunity 
Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
Volume 4, Issue 6, Pages (June 1996)
Volume 26, Issue 3, Pages (March 2007)
Volume 23, Issue 1, Pages (July 2005)
Volume 8, Issue 6, Pages (June 1998)
Durbaka V.R Prasad, Sabrina Richards, Xoi Muoi Mai, Chen Dong  Immunity 
Volume 7, Issue 3, Pages (September 1997)
Volume 8, Issue 6, Pages (June 1998)
Jack F Bukowski, Craig T Morita, Michael B Brenner  Immunity 
Volume 18, Issue 5, Pages (May 2003)
Ananda W Goldrath, Michael J Bevan  Immunity 
Giandomenica Iezzi, Klaus Karjalainen, Antonio Lanzavecchia  Immunity 
Volume 39, Issue 5, Pages (November 2013)
Zheng Pu, Scott B Lovitch, Elizabeth K Bikoff, Emil R Unanue  Immunity 
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Volume 27, Issue 2, Pages (August 2007)
Bonnie N Dittel, IrenaŠtefanova, Ronald N Germain, Charles A Janeway 
Volume 24, Issue 5, Pages (May 2006)
Jack F Bukowski, Craig T Morita, Michael B Brenner  Immunity 
Impaired Th2 Subset Development in the Absence of CD4
Volume 5, Issue 2, Pages (August 1996)
Volume 10, Issue 3, Pages (March 1999)
Volume 9, Issue 4, Pages (October 1998)
Volume 8, Issue 6, Pages (June 1998)
Zheng Pu, Scott B Lovitch, Elizabeth K Bikoff, Emil R Unanue  Immunity 
Volume 34, Issue 1, Pages (January 2011)
Volume 13, Issue 6, Pages (December 2000)
Volume 24, Issue 2, Pages (February 2006)
Volume 29, Issue 2, Pages (August 2008)
Novel Role of the Ras Cascade in Memory B Cell Response
Volume 5, Issue 1, Pages (July 1996)
CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4
Volume 16, Issue 2, Pages (February 2002)
Volume 5, Issue 3, Pages (September 1996)
Integrin Activation by R-ras
Volume 32, Issue 5, Pages (May 2010)
Volume 135, Issue 3, Pages (September 2008)
Volume 9, Issue 5, Pages (November 1998)
Volume 37, Issue 2, Pages (August 2012)
Andrew T Miller, Heather M Wilcox, Zhongbin Lai, Leslie J Berg 
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 9, Issue 3, Pages (September 1998)
Volume 15, Issue 2, Pages (August 2001)
Volume 9, Issue 4, Pages (October 1998)
Targeted Cleavage of Signaling Proteins by Caspase 3 Inhibits T Cell Receptor Signaling in Anergic T Cells  Irene Puga, Anjana Rao, Fernando Macian  Immunity 
Cytotoxic T Lymphocyte Antigen-4 Accumulation in the Immunological Synapse Is Regulated by TCR Signal Strength  Jackson G. Egen, James P. Allison  Immunity 
Volume 56, Issue 1, Pages (July 1999)
Negative Selection at the Pre-BCR Checkpoint Elicited by Human μ Heavy Chains with Unusual CDR3 Regions  Yoshiyuki Minegishi, Mary Ellen Conley  Immunity 
Notch 1 Signaling Regulates Peripheral T Cell Activation
The CD28 Signaling Pathway Regulates Glucose Metabolism
Phillip D. Holler, David M. Kranz  Immunity 
The CDR3 region of the Vγ1.1 chain is involved in ligand recognition by the Vγ1.1 Vδ6.3 TCR+ hybridomas. The CDR3 region of the Vγ1.1 chain is involved.
Volume 9, Issue 3, Pages (September 1998)
Vγ1.1Vδ6.3 TCRs transfected in TCR-deficient hybridomas are activated by anti-Vγ1.1, triggering IL-2 secretion. Vγ1.1Vδ6.3 TCRs transfected in TCR-deficient.
Volume 21, Issue 4, Pages (April 2013)
RORγt, a Novel Isoform of an Orphan Receptor, Negatively Regulates Fas Ligand Expression and IL-2 Production in T Cells  You-Wen He, Michael L Deftos,
Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent Experimental Allergic Encephalomyelitis  Margaret S. Bynoe,
Memory CD8+ T Cells Undergo Peripheral Tolerance
Altered Peptide Ligands Induce Delayed CD8-T Cell Receptor Interaction—a Role for CD8 in Distinguishing Antigen Quality  Pia P. Yachi, Jeanette Ampudia,
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

CD4 Augments the Response of a T Cell to Agonist but Not to Antagonist Ligands  Johannes Hampl, Yueh-hsiu Chien, Mark M Davis  Immunity  Volume 7, Issue 3, Pages 379-385 (September 1997) DOI: 10.1016/S1074-7613(00)80359-3

Figure 1 TCR and CD4 Expression Levels of Representative 2B4 Hybridoma Clones The original 2B4 T cell hybridoma was positively and negatively sorted by FACS for the expression of CD4 and cloned. CD4-positive clones (left panel) and CD4-negative clones (right panel) were picked and analyzed for their CD4 and CD3 expression with monoclonal antibodies GK1.5, conjugated to phycoerithrin, and 500a2, conjugated to FITC, respectively. Gates were set according to unstained controls (not shown), and the percentage of cells for each quadrant was calculated. Immunity 1997 7, 379-385DOI: (10.1016/S1074-7613(00)80359-3)

Figure 2 Antigen Reactivity of 2B4 T Cell Hybridoma Clones Reactivities of CD4-positive (A) and CD4-negative (B) clones are shown. The MCC(88–103) peptide was added at the indicated concentrations to 2 × 104/well 2B4 T cells and 2 × 104/well IEk-transfected CHO cells. After 18 hr, the supernatants were analyzed for their IL-2 content. Background values for the IL-2 ELISA were around ≤0.1 U/ml. Immunity 1997 7, 379-385DOI: (10.1016/S1074-7613(00)80359-3)

Figure 3 Recognition of MCC Peptide Variants by a CD4-Positive and a CD4-Negative 2B4 Clone Reactivities of CD4+ clone #70+ (A) and CD4− clone #24− are shown. The MCC peptide and variants were added at the indicated concentrations to 2 × 104/well 2B4 T cells and 2 × 104/well IEk-transfected CHO cells. After 18 hr, the supernatants were analyzed for their IL-2 content. Background values for the IL-2 ELISA were around ≤0.1 U/ml. Immunity 1997 7, 379-385DOI: (10.1016/S1074-7613(00)80359-3)

Figure 4 Effect of Anti-CD4 F(ab) Fragments on the Recognition of MCC and T102S Peptides by the 2B4 Hybridoma 2B4 T cells (2 × 104/well) were cultivated with IEk-transfected CHO cells (2 × 104/well) and 10 μM MCC, 0.1 μM MCC, or 10 μM T102S peptide in the absence (shaded bars) or presence (closed bars) of 10 μg/ml anti-CD4 F(ab)fragments. After 18 hr, the supernatants were analyzed for their IL-2 content. Background values for the IL-2 ELISA were around ≤0.01 U/ml. Immunity 1997 7, 379-385DOI: (10.1016/S1074-7613(00)80359-3)

Figure 5 TCR Antagonism of a CD4-Positive and a CD4-Negative 2B4 Clone IEk-transfected CHO cells were cultivated for 6 hr in the presence of 1 μM MCC (A and B) or the indicated concentrations of MCC peptide (C and D). After harvesting and washing, the cells were added at 2 × 104/well to 2 × 104/well 2B4 T cells in the presence of peptide variants K99R, T102G, and K99A (A and B) or in the absence (circles) or presence of peptide variants K99R (squares and triangles) (C and D). The T cell clones are either CD4-positive (closed symbols) or CD4-negative (open symbols). After 20 hr, the supernatants were analyzed for their IL-2 content. Background values for the IL-2 ELISA were around ≤0.01 U/ml. Immunity 1997 7, 379-385DOI: (10.1016/S1074-7613(00)80359-3)

Figure 6 Anti-CD4 and TCR Antagonists Inhibit 2B4 T Cell Activation through an Independent Mechanism (A) Agonist assay. A CD4+ 2B4 clone (#70+) was cultivated at 2 × 104/well with 2 × 104/well IEk-transfected CHO cells and MCC peptide in the absence (closed circles) or presence of various amounts of anti-CD4 F(ab) fragments (open symbols). (B) Antagonist assay. IEk-transfected CHO cells were cultivated for 6 hr in the presence of 10 nM MCC peptide. After harvesting and washing, the cells were added at 2 × 104/well to 2 × 104/well 2B4 T cells (clone #70+) in the presence of the indicated concentrations of peptide analogs K99R and the absence (closed circles) or presence (open symbols) of various amounts of anti-CD4 F(ab) fragments. After 18 hr, the supernatants were analyzed for their IL-2 content. Background values for the IL-2 ELISA were around ≤0.01 U/ml. Immunity 1997 7, 379-385DOI: (10.1016/S1074-7613(00)80359-3)